Boston Scientific announces upcoming investor conference schedule
Boston Scientific (NYSE: BSX) has announced its participation in two major investor conferences in May 2025. At the Bank of America's 2025 Health Care Conference on May 13, Dan Brennan (EVP & CFO) and Joe Fitzgerald (EVP & Group President, Cardiology) will engage in a 30-minute Q&A session starting at 8:00 a.m. PT. Later, on May 28, at Bernstein's 41st Annual Strategic Decisions Conference, Chairman & CEO Mike Mahoney and Dr. Ken Stein (SVP & Global Chief Medical Officer) will participate in a 50-minute Q&A session beginning at 8:00 a.m. ET. Both events will be available via live webcast and replay on the company's investor relations website.
Boston Scientific (NYSE: BSX) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel maggio 2025. Il 13 maggio, durante la Bank of America's 2025 Health Care Conference, Dan Brennan (EVP e CFO) e Joe Fitzgerald (EVP e Presidente del Gruppo Cardiologia) parteciperanno a una sessione di domande e risposte di 30 minuti a partire dalle 8:00 PT. Successivamente, il 28 maggio, alla 41ª Conferenza Annuale sulle Decisioni Strategiche di Bernstein, il Presidente e CEO Mike Mahoney e il Dr. Ken Stein (SVP e Chief Medical Officer Globale) prenderanno parte a una sessione Q&A di 50 minuti dalle 8:00 ET. Entrambi gli eventi saranno trasmessi in diretta streaming e disponibili in replica sul sito web delle relazioni con gli investitori della società.
Boston Scientific (NYSE: BSX) ha anunciado su participación en dos importantes conferencias para inversores en mayo de 2025. El 13 de mayo, en la Conferencia de Atención Médica 2025 de Bank of America, Dan Brennan (EVP y CFO) y Joe Fitzgerald (EVP y Presidente del Grupo de Cardiología) participarán en una sesión de preguntas y respuestas de 30 minutos a partir de las 8:00 a.m. PT. Más tarde, el 28 de mayo, en la 41ª Conferencia Anual de Decisiones Estratégicas de Bernstein, el presidente y CEO Mike Mahoney y el Dr. Ken Stein (SVP y Director Médico Global) participarán en una sesión de preguntas y respuestas de 50 minutos a partir de las 8:00 a.m. ET. Ambos eventos estarán disponibles mediante webcast en vivo y repetición en el sitio web de relaciones con inversores de la compañía.
Boston Scientific (NYSE: BSX)는 2025년 5월에 열리는 두 개의 주요 투자자 컨퍼런스에 참여한다고 발표했습니다. 5월 13일에 열리는 Bank of America 2025 헬스케어 컨퍼런스에서 Dan Brennan (EVP 겸 CFO)과 Joe Fitzgerald (EVP 겸 심장학 그룹 사장)가 오전 8시(태평양 표준시)부터 30분간 Q&A 세션을 진행할 예정입니다. 이어서 5월 28일에는 Bernstein의 제41회 연례 전략적 결정 컨퍼런스에서 회장 겸 CEO Mike Mahoney와 Dr. Ken Stein (SVP 겸 글로벌 최고 의료 책임자)이 오전 8시(동부 표준시)부터 50분간 Q&A 세션에 참여합니다. 두 행사 모두 회사 투자자 관계 웹사이트를 통해 실시간 웹캐스트 및 다시보기로 제공됩니다.
Boston Scientific (NYSE : BSX) a annoncé sa participation à deux grandes conférences pour investisseurs en mai 2025. Le 13 mai, lors de la Bank of America's 2025 Health Care Conference, Dan Brennan (EVP et CFO) et Joe Fitzgerald (EVP et Président du groupe Cardiologie) animeront une session de questions-réponses de 30 minutes à partir de 8h00 PT. Ensuite, le 28 mai, lors de la 41e conférence annuelle sur les décisions stratégiques de Bernstein, le président-directeur général Mike Mahoney et le Dr Ken Stein (SVP et directeur médical mondial) participeront à une session de questions-réponses de 50 minutes à partir de 8h00 ET. Les deux événements seront diffusés en direct par webcast et disponibles en replay sur le site des relations investisseurs de la société.
Boston Scientific (NYSE: BSX) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Mai 2025 bekanntgegeben. Am 13. Mai werden Dan Brennan (EVP & CFO) und Joe Fitzgerald (EVP & Gruppenpräsident Kardiologie) auf der Bank of America 2025 Health Care Conference an einer 30-minütigen Fragerunde ab 8:00 Uhr PT teilnehmen. Später, am 28. Mai, nehmen Chairman & CEO Mike Mahoney und Dr. Ken Stein (SVP & Global Chief Medical Officer) an der 50-minütigen Fragerunde auf Bernsteins 41. jährlicher Strategic Decisions Conference ab 8:00 Uhr ET teil. Beide Veranstaltungen werden live per Webcast übertragen und sind anschließend auf der Investor-Relations-Webseite des Unternehmens verfügbar.
- None.
- None.
On May 13, 2025, Dan Brennan, executive vice president and chief financial officer, and Joe Fitzgerald, executive vice president and group president, Cardiology, will participate in a 30-minute question-and-answer session with the host analyst at Bank of America's 2025 Health Care Conference. The session will begin at approximately 8:00 a.m. PT / 11:00 a.m. ET.
On May 28, 2025, Mike Mahoney, chairman and chief executive officer, and Ken Stein, M.D., senior vice president and global chief medical officer, will participate in a 50-minute question-and-answer session with the host analyst at Bernstein's 41st Annual Strategic Decisions Conference. The session will begin at approximately 8:00 a.m. ET.
A live webcast and replay for each event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X.
CONTACTS:
Chanel Hastings
Media Relations
(508) 382-0288 (office)
Chanel.Hastings@bsci.com
Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-upcoming-investor-conference-schedule-302442449.html
SOURCE Boston Scientific Corporation
FAQ
When is Boston Scientific (BSX) presenting at the Bank of America Health Care Conference 2025?
Who will represent BSX at Bernstein's Strategic Decisions Conference in May 2025?
How can investors access Boston Scientific's conference presentations in May 2025?
What is the duration of BSX's Q&A session at Bernstein's conference?
